Global Critical Care Devices Market is poised to accrue remarkable gains through 2032, credited to the growing demand for ventilators for disease management. Moreover, the increasing incidence of chronic respiratory disorders and the associated comorbidities has propelled the demand for ventilators. As per the NCD Alliance, an estimated 550 million people globally are diagnosed with chronic respiratory diseases.
Moreover, the growing emphasis of industry players on R&D activities for developing ventilators in therapeutic space is also working in favor of industry expansion. In fact, in January 2023, Getinge AB, a Swedish medical technology company, announced the launch of its new Servo-c mechanical ventilator, providing lung-protective therapeutic tools for the expansion of its ICU offerings.
Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/3936
Overall, the critical care devices market is segmented based on product, application, end-use, and region.
On the basis of product, the critical care devices industry from the ECG devices segment is expected to register significant gains through 2032, owing to ongoing product innovations in the field. For instance, in January 2022, Royal Philips, a global health technology provider, announced the launch of the first-ever at-home full-service 12-lead electrocardiogram (ECG) solution. It is a clinical-grade patient-focused ECG solution that pairs data readings comparable to clinical ECGs to bring innovation across the care continuum.
In terms of application, the critical care devices market share from the neurology segment is poised to grow at over 6% CAGR from 2023 to 2032. The growing occurrence of neurological diseases such as Alzheimer's disease, multiple sclerosis (MS), traumatic brain injury, epilepsy, and others has proliferated the need for critical care devices. As per the WHO, epilepsy affects around 5 million people globally every year. Moreover, recent advancements in neurological devices will further create a strong impetus for segment expansion.
With respect to end-use, the critical care devices market size from the ambulatory surgical centers segment is anticipated to grow at a substantial CAGR from 2023 to 2032. The high availability of technologically advanced critical care devices and less cost of treatment has increased patient footfall in ambulatory surgical centers. Additionally, shorter hospital stays and low risk of hospital-acquired infections have made them the preferred healthcare provider for the treatment of severe diseases.
Regionally speaking, the Asia Pacific critical care devices market is slated to record a valuation of over USD 25 billion by 2032. The rising prevalence of severe illnesses such as cardiovascular disorders, cancer, and others has bolstered the demand for critical care devices in the region. As per the Journal of Thoracic Oncology, lung cancer makes up 8.1% of all cancer-related deaths in India. Regional growth can also be ascribed to the robust presence of prominent industry players such as Mindray, Asahi Kasei Corporation, and others who are consistently engaged in product innovations.
Request for customization @ https://www.gminsights.com/roc/3936
Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Critical care devices industry 360° synopsis, 2018 - 2032
2.1.1 Business trends (USD Million & 000’ Units)
2.1.2 Product trends (USD Million & 000’ Units)
2.1.3 Application field trends (USD Million & 000’ Units)
2.1.4 End-use trends (USD Million & 000’ Units)
2.1.5 Regional trends (USD Million & 000’ Units)
Browse complete Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/critical-care-devices-market
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: 1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email:[email protected]
COVID-19 Impact Analysis on Critical Care Antiarrhythmic Drugs Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the critical care antiarrhythmic drugs market include Amomed Pharma GmbH, Mayne Pharma, Sanofi, Mylan N.V., Pfizer Inc., Upsher-Smith Laboratories, LLC., GlaxoSmithKline plc, Baxter International Inc., Novartis AG.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Critical Care Antiarrhythmic Drugs Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/critical-care-antiarrhythmic-drugs-market/download-sampleMarket DynamicsThe global critical care antiarrhythmic drugs market is foreseen to boom attributed to the increasing prevalence of cardiovascular diseases (CVDs).
Cardiovascular diseases (CVDs) are the prime cause of death globally, taking the lives of estimated 17.9 million people annually.
This is likely to hamper market growth during the forecast period.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
Middle East and Africa Critical Care Equipment (CCE) Market information, by Type (Patient Monitor, Medical Ventilator, Dialysis, IV Pumps, Infusion pump, Suction Apparatus, and others), by End users (Hospitals, Research laboratories and others) - Forecast to 2027Overview:The Middle East & Africa (MEA) critical care equipment (CCE) market can grow substantially to a valuation of USD 1061.4 million during the forecast period (2017-2023) from a measured valuation of USD 681.2 million in 2016.
Market Research Future (MRFR) explains in a detailed report that the leap will take place with an impressive CAGR of 5.7%.
The climatic condition of the region triggers many diseases that need immediate, intense care owing to which a revamping of the critical care market is of the utmost importance.
Governments in the region have realized the urgency of such developments and the region is also getting global funding.However, on the downside, the region has low per capita income, and some of the poorest countries of the world belong here.
Recently, Nyeri County Referral Hospital in Kenya collaborated with Philips to increase their service efficiency by providing the necessary training to their staff and implementing new machines that could prove vital in saving lives.Trivitron Healthcare Private Limited (“Trivitron”), an Indian market giant, is collaborating with the Investment Funds for Health in Africa (“IFHA”), a leading private equity investor in the healthcare sector in Africa, to launch Trivitron Healthcare Africa B.V. (“THA”), which will have its focus solely on the African continent.
Hospitals constitute 80.60% of the market, and its impact is substantial in the region.Regional Analysis:The MEA market for CCE witnesses the U.A.E leading from the front as the country is financially superior and per capita income is quite high.
